27 studies found for:    weill AND injection medications | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration
Conditions: Hypogonadism;   Opioid-Related Disorders;   Male Infertility
Interventions: Drug: Clomiphene citrate;   Drug: Placebo
2 Recruiting Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)
Condition: Hilar Cholangiocarcinoma
Interventions: Drug: Photodynamic therapy-Photofrin;   Procedure: Stenting procedure;   Drug: Chemotherapy regimen Gemcitabine/Cisplatin
3 Recruiting BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors
Conditions: Metastatic Cancer;   Cancer;   Solid Tumor
Interventions: Drug: BP31510 monotherapy;   Drug: BP31510 in combination with chemotherapy
4 Recruiting Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion
Condition: Central Retinal Vein Occlusion
Intervention: Drug: Tissue Plasminogen Activator
5 Unknown  Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction
Condition: Overactive Bladder
Intervention: Drug: Botox/Placebo
6 Recruiting Clinical Trials to Reduce the Risk of Antimicrobial Resistance
Condition: Bacterial Pneumonia
Interventions: Drug: IV meropenem;  parenteral aminoglycoside;   Drug: I.V. Meropenem
7 Recruiting Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Condition: HER2 Low to Intermediate Breast Cancer
Interventions: Biological: NeuVax™ vaccine;   Biological: Leukine® (sargramostim, GM-CSF) and water for injection
8 Recruiting Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Angioedema
Condition: Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Interventions: Drug: Icatibant;   Drug: Placebo
9 Recruiting A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
Conditions: Carcinoid Tumor of the Small Bowel;   Neuroendocrine Tumour
Interventions: Drug: Octreotide LAR;   Drug: 177Lu-DOTA0-Tyr3-Octreotate
10 Recruiting Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Condition: High Risk Acute Myeloid Leukemia
Interventions: Drug: CPX-351;   Drug: 7+3 (cytarabine and daunorubicin)
11 Recruiting Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis
Condition: Myelofibrosis
Intervention: Drug: Peginterferon alfa-2a
12 Recruiting Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Condition: Dumping Syndrome Patients
Intervention: Drug: SOM230
13 Recruiting Sofosbuvir Plus Ribavirin For Acute Hepatitis C in HIV-infected Individuals (SWIFT-C)
Conditions: HIV-1 Infection;   Hepatitis
Interventions: Drug: Ribavirin;   Drug: Sofosbuvir
14 Recruiting Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: BMS-936559;   Drug: Placebo for BMS-936559
15 Recruiting Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
Conditions: Critical Limb Ischemia;   Peripheral Arterial Disease;   Peripheral Vascular Disease
Interventions: Device: Bone marrow concentration device;   Procedure: Placebo procedure (sham)
16 Recruiting Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma
Conditions: Lymphoma, Extranodal NK-T-Cell;   EBV
Intervention: Biological: CMD-003
17 Recruiting Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
Conditions: Glioblastoma;   Small Cell Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Component
Interventions: Drug: Rindopepimut (CDX-110) with GM-CSF;   Drug: Temozolomide;   Drug: KLH
18 Recruiting Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
Conditions: Unresectable Cholangiocarcinoma;   Biliary Obstruction;   Stent Obstruction;   Biliary Stricture
Intervention: Procedure: Photodynamic Therapy
19 Recruiting Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection
Condition: Brain Tumors With Ill-defined Margins
Intervention: Drug: Indigo carmine
20 Recruiting F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
Condition: Bone Metastases
Intervention: Device: Bone Scan: F18-Fluoride PET/CT or TC-MDP

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
Indicates status has not been verified in more than two years